RougeTx
Latest round
- Series A
Last raised
- Oct 2026
Total raised
- $58M
Investors
- 9
About RougeTx
Founded in 2024 and based in Naarden, Netherlands, RougeTx is a biotechnology company that develops small-molecule therapies that target pericytes, specialized cells involved in maintaining blood vessel stability and function for rare vascular disorder.
Who invested in RougeTx
9 investors across 1 round
See all investors in RougeTx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 6, 2026
Amount
$58M
Investors
Questions about RougeTx
Who invested in RougeTx?
RougeTx has 9 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RougeTx raised?
RougeTx has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did RougeTx last raise money?
RougeTx's most recent round on record is a Series A, in Oct 2026.
What does RougeTx do?
Founded in 2024 and based in Naarden, Netherlands, RougeTx is a biotechnology company that develops small-molecule therapies that target pericytes, specialized cells involved in maintaining blood vessel stability and function for rare vascular disorder.
Where is RougeTx headquartered?
RougeTx is headquartered in Naarden, Netherlands.
Which VCs invest in companies like RougeTx?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at RougeTx's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like RougeTx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.